A sneak peek at our first BIO interview: Mr. Mark Womack, CEO of BioCina.
A sneak peek at our first BIO interview: Mr. Mark Womack, CEO of BioCina.
Shoutout to Steve Favaloro of Genezen for being one of our 20 interview subjects at this year’s BIO in Boston.
Props to our Senior Scientific Research Director, April Stanley, for a stellar interview with Gina Ford and the Women In Bio team at this year’s BIO. Keep your eyes on Pharma’s Almanac for the upcoming release.
We met with Pep Gubau, CEO of Aizon, at INTERPHEX to learn more about their AI-powered software, which delivers predictive insights that improve yield, minimize deviations, and ensure product quality in pharmaceutical manufacturing. Check out the full interview at www.pharmasalmanac.com.
The seventh installment of the “Road To…” Series: The Road to 30 Years, during which Nigel and Mark are answering the most common 30 questions friends, clients, and staff ask. The 1971 Raleigh Choppers, along with the FILA and Sergio Tacchini track suits, are just a special bonus for the audience.
We met with Joanna Pezzini, CEO, and Kevin Hill-Byrne, CTO of PAK BioSolutions, at INTERPHEX to talk about the future of end-to-end continuous biomanufacturing. Check out the full interview at www.pharmasalmanac.com.
We met with Brandon Zurawlow, Chief Operating Officer at CS Analytical, at INTERPHEX for his insights into the critical role packaging plays in product safety and integrity, especially as therapies become more sensitive and regulatory expectations increase. Check out the full interview at www.pharmasalmanac.com.
We met with Kris Tompkins, Pharma Industry & OEM Manager at Loma Systems, at INTERPHEX to discuss the company’s leadership in in-line inspection solutions for the pharmaceutical sector. Check out the full interview at www.pharmasalmanac.com.
We met with Ronny Zingre, Owner and CEO of MBV AG, at INTERPHEX to explore why his company’s microbial air samplers have been trusted across the pharma and biopharma industries for three decades. Check out the full interview at www.pharmasalmanac.com.
We met with Charles Ruban, CEO of VERDOT Biotechnologies, at INTERPHEX to explore the company’s 70-year history of designing and manufacturing custom purification solutions that meet the evolving needs of therapeutic manufacturers worldwide. Check out the full interview at www.pharmasalmanac.com.